Results 81 to 90 of about 557 (132)

GLP-1 Receptor Agonists for Treating Alcohol Use Disorder: A Critical Review. [PDF]

Alcohol Clin Exp Res (Hoboken)
Woo S, Zhu G, Castro C, Phuong A, Roy A, Davis CN, Kranzler HR.   +6 more
europepmc   +1 more source

Weight Loss, Obesity Medication, and Risk of Obesity-Associated Cancer: A Meta-Analysis of Randomized Controlled Trials. [PDF]

Obesity (Silver Spring)
Li C, Lin C, Cai X, Lv F, Yang W, Ji L.
europepmc   +1 more source

A Lineup for Next Anti-Obesity Medicines: Beyond Incretin-Based Pharmacotherapy. [PDF]

Pharmaceuticals (Basel)
Lee S, Song H, Kwon Y.
europepmc   +1 more source

ESI Clinical Practice Guidelines for the Evaluation and Management of Obesity in India - An Update (2025). [PDF]

Indian J Endocrinol Metab
Madhu SV, Kapoor N, Das S, Raizada N, Kalra S.   +4 more
europepmc   +1 more source

Pharmacological Therapy for Metabolic Dysfunction-Associated Steatotic Liver Disease in a New Era for Obesity and Metabolic Medicine: A State-of-the-Art Review. [PDF]

J Obes Metab Syndr
Chan WK, Leung HK, Tan GJ, Lim QH, Lim LL, Ratnasingam J, Vethakkan SR.   +6 more
europepmc   +1 more source

Management of Obese Patients with Cardiovascular Disease with Emerging Weight-Lowering Drugs: A Narrative Review. [PDF]

Biomedicines
Ciarloni A, Salvio G, Bordoni M, Giacchetti G, Balercia G.   +4 more
europepmc   +1 more source

Optimal Medical Therapy Targeting Metabolic Status for Secondary Prevention in Patients Undergoing Percutaneous Coronary Intervention. [PDF]

J Clin Med
Forzano I, Narciso V, Canonico ME, Castiello DS, Florimonte D, Manzi L, Semplice F, Vallone DM, Cristiano S, Spinelli A, D'Alconzo D, Paolillo R, Giugliano G, Cesaro A, Gragnano F, Calabrò P, Esposito G, Gargiulo G.   +17 more
europepmc   +1 more source

Eloralintide, a selective, long-acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept. [PDF]

Diabetes Obes Metab
Bhattachar S, Tham LS, Tidemann-Miller B, Ibriga H, Qu H, Briere DA, Haupt A, Mather KJ, Pratt E.   +8 more
europepmc   +1 more source

GLP-1 Medicines in Perspective: Approaches to Optimize Outcome. [PDF]

J Diabetes
Bloomgarden Z.
europepmc   +1 more source

Oral Health Implications of GLP-1 Receptor Agonists and Other Incretin-Based Therapies. [PDF]

J Clin Med
Bijoch J.
europepmc   +1 more source